Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 2, 2014, Pages 303-310

  Smit, Marieke ^a   Zuidhof, Annet B ^a   Bos, Sophie I T ^a   Maarsingh, Harm ^a   Gosens, Reinoud ^a   Zaagsma, Johan ^a   Meurs, Herman ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; OLODATEROL; TIOTROPIUM BROMIDE;

ACUTE DISEASE; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMATIC STATE; BRONCHOPROTECTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; EARLY ASTHMATIC REACTION; GUINEA PIG MODEL; LATE ASTHMATIC REACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

EID: 84893126080     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.208439     Document Type: Article

References (41)

1. Bos IS, Gosens R, Zuidhof AB, Schaafsma D, Halayko AJ, Meurs H, and Zaagsma J (2007) Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30:653-661.
2. Boterman M, Elzinga CR, Wagemakers D, Eppens PB, Zaagsma J, and Meurs H (2005) Potentiation of beta-adrenoceptor function in bovine tracheal smooth muscle by inhibition of protein kinase C. Eur J Pharmacol 516:85-92.
3. Boterman M, Smits SR, Meurs H, and Zaagsma J (2006) Protein kinase C potentiates homologous desensitization of the beta2-adrenoceptor in bovine tracheal smooth muscle. Eur J Pharmacol 529:151-156.
4. Bousquet J, Jeffery PK, Busse WW, Johnson M, and Vignola AM (2000) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720-1745.
5. Bouyssou T, Casarosa P, Naline E, Pestel S, Konetzki I, Devillier P, and Schnapp A (2010a) Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models. J Pharmacol Exp Ther 334:53-62.
6. Bouyssou T, Hoenke C, Rudolf K, Lustenberger P, Pestel S, Sieger P, Lotz R, Heine C, Büttner FH, and Schnapp A, et al. (2010b) Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy. Bioorg Med Chem Lett 20:1410-1414.
7. Buels KS, Jacoby DB, and Fryer AD (2012) Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma. Br J Pharmacol 165:1501-1514.
8. Casarosa P, Kollak I, Kiechle T, Ostermann A, Schnapp A, Kiesling R, Pieper M, Sieger P, and Gantner F (2011) Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol. J Pharmacol Exp Ther 337:600-609.
9. Chuang TT, Iacovelli L, Sallese M, and De Blasi A (1996) G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci 17:416-421.
10. Chuang TT, LeVine H, 3rd, and De Blasi A (1995) Phosphorylation and activation of beta-adrenergic receptor kinase by protein kinase C. J Biol Chem 270: 18660-18665.
11. Cockcroft DW and Davis BE (2006) Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 118:551-559, quiz 560-561.
12. Gosens R, Bos IS, Zaagsma J, and Meurs H (2005) Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 171:1096-1102.
13. Gosens R, Zaagsma J, Meurs H, and Halayko AJ (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7:73.
14. Grandordy BM, Mak JC, and Barnes PJ (1994) Modulation of airway smooth muscle beta-adrenoceptor function by a muscarinic agonist. Life Sci 54:185-191.
15. Gross NJ (2006) Anticholinergic agents in asthma and COPD. Eur J Pharmacol 533: 36-39.
16. Jenne JW, Shaughnessy TK, Druz WS, Manfredi CJ, and Vestal RE (1987) In vivo functional antagonism between isoproterenol and bronchoconstrictants in the dog. J Appl Physiol (1985) 63:812-819.
17. Kerstjens HA, Disse B, Schröder-Babo W, Bantje TA, Gahlemann M, Sigmund R, Engel M, and van Noord JA (2011) Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 128:308-314.
18. Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, and Bateman ED (2012) Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 367: 1198-1207.
19. Kistemaker LE, Oenema TA, Meurs H, and Gosens R (2012) Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sci 91:1126-1133.
20. Lanes SF, Garrett JE, Wentworth CE, 3rd, Fitzgerald JM, and Karpel JP (1998) The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest 114:365-372.
21. Meurs H, Gosens R, and Zaagsma J (2008) Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models. Eur Respir J 32:487-502.
22. Meurs H, Roffel AF, Elzinga CRS, and Zaagsma J (2001) Muscarinic receptorb-adrenoceptor cross-talk in airway smooth muscle, in Muscarinic Receptors in Airways Diseases (Zaagsma J, Meurs H, and Roffel AF eds) pp 121-158, Birkhäuser Verlag, Basel, Switzerland
23. Meurs H, Santing RE, Remie R, Van der Mark TW, Westerhof FJ, Zuidhof AB, Bos IS, and Zaagsma J (2006) A guinea pig model of acute and chronic asthma using permanently instrumented and unrestrained animals. Nat Protoc 1:840-847.
24. O'Byrne PM, Van der Linde J, Cockcroft DW, Gauvreau GM, Brannan JD, Fitzgerald M, Watson RM, Milot J, Davis B, and O'Connor M, et al. (2009) Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta (2)-agonist, in patients with mild asthma. J Allergy Clin Immunol 124:1217-1221.
25. Ohta S, Oda N, Yokoe T, Tanaka A, Yamamoto Y, Watanabe Y, Minoguchi K, Ohnishi T, Hirose T, and Nagase H, et al. (2010) Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 40: 1266-1275.
26. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, and Cherniack RM, et al.; National Heart, Lung, and Blood Institute Asthma Clinical Research Network (2010) Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 363: 1715-1726.
27. Pyne NJ, Freissmuth M, and Palmer S (1992a) Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C. Biochem J 285:333-338.
28. Pyne NJ, Grady MW, Shehnaz D, Stevens PA, Pyne S, and Rodger IW (1992b) Muscarinic blockade of beta-adrenoceptor-stimulated adenylyl cyclase: the role of stimulatory and inhibitory guanine-nucleotide binding regulatory proteins (Gs and Gi). Br J Pharmacol 107:881-887.
29. Raffestin B, Cerrina J, Boullet C, Labat C, Benveniste J, and Brink C (1985) Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther 233:186-194.
30. Raemdonck K, de Alba J, Birrell MA, Grace M, Maher SA, Irvin CG, Fozard JR, O'Byrne PM, and Belvisi MG (2012) A role for sensory nerves in the late asthmatic response. Thorax 67:19-25.
31. Rodrigo G, Rodrigo C, and Burschtin O (1999) A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 107:363-370.
32. Rossoni G, Manfredi B, Razzetti R, Civelli M, and Berti F (2007) Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs. Pulm Pharmacol Ther 20:250-257.
33. Santing RE, Meurs H, Van der Mark TW, Remie R, Oosterom WC, Brouwer F, and Zaagsma J (1992) A novel method to assess airway function parameters in chronically instrumented, unrestrained guinea-pigs. Pulm Pharmacol 5:265-272.
34. Sibley DR and Lefkowitz RJ (1985) Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317:124-129.
35. Ten Berge RE, Santing RE, Hamstra JJ, Roffel AF, and Zaagsma J (1995) Dysfunction of muscarinic M2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs. Br J Pharmacol 114:881-887.
36. Torphy TJ, Zheng C, Peterson SM, Fiscus RR, Rinard GA, and Mayer SE (1985) Inhibitory effect of methacholine on drug-induced relaxation, cyclic AMP accumulation, and cyclic AMP-dependent protein kinase activation in canine tracheal smooth muscle. J Pharmacol Exp Ther 233:409-417.
37. Van Amsterdam RG, Brouwer F, and Zaagsma J (1989a) Analysis of the betaadrenoceptor mediated inhibition of IgG1 and IgE dependent guinea-pig anaphylactic tracheal smooth muscle contraction. Agents Actions 26:48-51.
38. Van Amsterdam RG, Meurs H, Brouwer F, Postema JB, Timmermans A, and Zaagsma J (1989b) Role of phosphoinositide metabolism in functional antagonism of airway smooth muscle contraction by beta-adrenoceptor agonists. Eur J Pharmacol 172:175-183.
39. Van Amsterdam RG, Meurs H, Ten Berge RE, Veninga NC, Brouwer F, and Zaagsma J (1990) Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by beta-adrenoceptor agonists. Am Rev Respir Dis 142:1124-1128.
40. Van Noord JA, Smeets JJ, Drenth BM, Rascher J, Pivovarova A, Hamilton AL, and Cornelissen PJ (2011) 24-Hour bronchodilation following a single dose of the novel b(2)-agonist olodaterol in COPD. Pulm Pharmacol Ther 24:666-672.
41. Westerhof FJ, Zuidhof AB, Kok L, Meurs H, and Zaagsma J (2005) Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity. Eur Respir J 25:864-872.